Episode Mentions
The Daily · May 17, 2026
Can We Reverse Aging?
“Longevity biotech startup that received approximately $200 million investment from Sam Altman of OpenAI”
Cellular Rejuvenation TechnologyYamanaka Factors and Gene TherapyLongevity Science Research
View AnalysisExtend Podcast with Darshan Shah, MD · Apr 30, 2026
160. Dr. Kara Fitzgerald on Biological Age, Epigenetic Clocks, and the Future of Aging Reversal
“Biotech company advancing Yamanaka factor therapies, currently in Phase 2 trials in Australia for age-reversal applications”
Epigenetic clocks and biological age measurementPolyphenol compounds and gene expressionYamanaka factors and cellular reprogramming
View AnalysisAI + a16z · Feb 10, 2026
Sam Altman on Sora, Energy, and Building an AI Empire
“Longevity company in Altman's investment portfolio working on aging research”
Artificial General Intelligence (AGI) DevelopmentAI Infrastructure and Data CentersScientific Discovery Through AI
View AnalysisThe Artificial Intelligence Show · Jan 29, 2025
#133: DeepSeek, US vs. China AI War, Anthropic CEO: AI Could Surpass Humans by 2027, OpenAI Plans AI for Advanced Coding, & Meta’s 1.3 Million GPUs
DeepSeek AI breakthrough and market disruptionUS-China AI competition and national security implicationsAI job displacement in software engineering
View Analysis